Literature DB >> 20709719

Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative study.

K McElhone1, J Abbott, J Gray, A Williams, L-S Teh.   

Abstract

We sought to understand the patients' 'lived experiences of systemic lupus erythematosus (SLE)' by exploring, describing and clarifying the patients' perspective of how they felt about having SLE and how the disease impacted on their lives, both positively and/or negatively. An interpretative phenomenological approach was employed. Semi-structured interviews were undertaken with 30 females with SLE across a wide range of age (21 to 75 years), disease characteristics, disease duration (1 to 28 years) and ethnicity (Whites, South Asians). Eleven themes emerged as important to the patients: prognosis and course of disease; body image; effects of treatment; emotional difficulties; inability to plan due to disease unpredictability; fatigue; pain; career prospects and loss of income; memory loss/concentration; reliance on others to assist with everyday tasks; and pregnancy issues. Most patients reported a negative impact of SLE on their lives although a few patients found positive aspects to having SLE. The findings of this study identified themes important to patients with SLE and these themes will inform clinicians on the patients' perspective of having SLE.

Entities:  

Mesh:

Year:  2010        PMID: 20709719     DOI: 10.1177/0961203310378668

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  23 in total

Review 1.  Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus.

Authors:  Anisha B Dua; Zahi Touma; Sergio Toloza; Meenakshi Jolly
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

2.  Understanding systemic lupus erythematosus patients' desired outcomes and their perceptions of the risks and benefits of using corticosteroids.

Authors:  X Ng; S dosReis; R Beardsley; L Magder; C D Mullins; M Petri
Journal:  Lupus       Date:  2017-08-31       Impact factor: 2.911

3.  Feasibility, Validity, and Reliability of the 10-item Patient Reported Outcomes Measurement Information System Global Health Short Form in Outpatients with Systemic Lupus Erythematosus.

Authors:  Shanthini Kasturi; Jackie Szymonifka; Jayme C Burket; Jessica R Berman; Kyriakos A Kirou; Alana B Levine; Lisa R Sammaritano; Lisa A Mandl
Journal:  J Rheumatol       Date:  2018-02-01       Impact factor: 4.666

4.  Systematic review of digital and non-digital non-pharmacological interventions that target quality of life and psychological outcomes in adults with systemic lupus erythematosus.

Authors:  Angela Chang; Nathan W Winquist; Annie B Wescott; Emily G Lattie; Andrea K Graham
Journal:  Lupus       Date:  2021-03-28       Impact factor: 2.911

Review 5.  Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance.

Authors:  Laura Holloway; Louise Humphrey; Louise Heron; Claire Pilling; Helen Kitchen; Lise Højbjerre; Martin Strandberg-Larsen; Brian Bekker Hansen
Journal:  Health Qual Life Outcomes       Date:  2014-07-22       Impact factor: 3.186

6.  Cognitive dysfunction among people with systemic lupus erythematosus is associated with reduced participation in daily life.

Authors:  Moon Young Kim; Deepali Sen; Ronald R Drummond; Matthew C Brandenburg; Kathryn Lp Biesanz; Alfred Hj Kim; Seth A Eisen; Carolyn M Baum; Erin R Foster
Journal:  Lupus       Date:  2021-04-01       Impact factor: 2.911

7.  Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trials.

Authors:  Vibeke Strand; Roger A Levy; Ricard Cervera; Michelle A Petri; Helen Birch; William W Freimuth; Z John Zhong; Ann E Clarke
Journal:  Ann Rheum Dis       Date:  2013-03-22       Impact factor: 19.103

8.  Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006.

Authors:  Vibeke Strand; Michelle Petri; Kenneth Kalunian; Caroline Gordon; Daniel J Wallace; Kathryn Hobbs; Lexy Kelley; Brian Kilgallen; William A Wegener; David M Goldenberg
Journal:  Rheumatology (Oxford)       Date:  2013-11-22       Impact factor: 7.580

9.  Association of age with health-related quality of life in a cohort of patients with systemic lupus erythematosus: the Georgians Organized Against Lupus study.

Authors:  Laura Plantinga; S Sam Lim; C Barrett Bowling; Cristina Drenkard
Journal:  Lupus Sci Med       Date:  2016-07-19

10.  Experiences of Iranian female patients with systemic lupus erythematosus: A qualitative study.

Authors:  Zahra Behboodi Moghadam; Seyedeh Tahereh Faezi; Armin Zareian; Elham Rezaei
Journal:  Arch Rheumatol       Date:  2020-12-10       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.